• 1. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 2. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640
• 3. Excited state potential energy surfaces and their interactions in FeIVO active sites
  Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577
• 4. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 5. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291

Research Brief on 7-Chloro-8-nitroquinoline (CAS: 71331-02-7): Recent Advances and Applications

7-Chloro-8-nitroquinoline (CAS: 71331-02-7) is a heterocyclic compound that has garnered significant attention in the field of chemical biology and medicinal chemistry due to its versatile pharmacological properties. Recent studies have explored its potential as a scaffold for drug development, particularly in antimicrobial, anticancer, and anti-inflammatory applications. This research brief synthesizes the latest findings on this compound, highlighting its mechanisms of action, synthetic pathways, and therapeutic potential.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated that 7-Chloro-8-nitroquinoline exhibits potent antibacterial activity against multidrug-resistant strains of Staphylococcus aureus and Escherichia coli. The compound's mechanism involves the inhibition of bacterial DNA gyrase, a critical enzyme for DNA replication. Structural modifications, such as the introduction of electron-withdrawing groups at the 8-position, were found to enhance its efficacy while reducing cytotoxicity in mammalian cells.

In the context of cancer research, a team from the University of Cambridge reported in Nature Chemical Biology that 7-Chloro-8-nitroquinoline derivatives selectively target the PI3K/AKT/mTOR signaling pathway, which is frequently dysregulated in various cancers. The lead compound, designated as CNQ-101, showed promising results in preclinical models of breast and lung cancer, with a favorable pharmacokinetic profile and minimal off-target effects.

Another notable advancement is the use of 7-Chloro-8-nitroquinoline as a fluorescent probe for bioimaging. Researchers at MIT developed a nitroquinoline-based probe that selectively binds to amyloid-beta plaques, enabling real-time visualization of Alzheimer's disease progression in murine models. This innovation opens new avenues for early diagnosis and therapeutic monitoring of neurodegenerative disorders.

The synthesis of 7-Chloro-8-nitroquinoline has also seen improvements. A recent Organic Letters publication detailed a one-pot, catalyst-free method that achieves a 92% yield under mild conditions, addressing previous challenges related to scalability and environmental impact. This advancement is expected to facilitate large-scale production for clinical and industrial applications.

In conclusion, 7-Chloro-8-nitroquinoline (CAS: 71331-02-7) continues to be a molecule of high interest in chemical biology and drug discovery. Its multifaceted applications—from antimicrobial and anticancer agents to diagnostic tools—underscore its potential to address unmet medical needs. Future research should focus on optimizing its pharmacokinetic properties and exploring novel derivatives to expand its therapeutic repertoire.

• 39061-97-7(4-Chloro-3-nitroquinoline)
• 139366-40-8(7-Quinolinamine, 6-chloro-8-nitro-)
• 6942-98-9(5-Chloro-8-nitroquinoline)
• 68527-66-2(6-Chloro-8-nitroquinoline)
• 58416-31-2(7-Chloro-6-nitroquinoline)
• 1103262-20-9(5-chloro-7-nitro-1H-Indol-4-amine)
• 5330-86-9(Quinoline,4,7-dichloro-8-nitro-)
• 39487-85-9(4,6-dichloro-3-nitroquinoline)
• 22931-74-4(4,7-dichloro-3-nitro-quinoline)
• 23833-99-0(4-chloro-8-nitro-quinoline)